Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Stephanie V Avila"'
Autor:
Kapil K Saharia, Jennifer S Husson, Silke V Niederhaus, Thierry Iraguha, Stephanie V Avila, Youngchae J Yoo, Nancy M Hardy, Xiaoxuan Fan, Destiny Omili, Alice Crane, Amber Carrier, Wen Y Xie, Erica Vander Mause, Kim Hankey, Sherri Bauman, Patricia Lesho, Heather D Mannuel, Ashish Ahuja, Minu Mathew, James Avruch, John Baddley, Olga Goloubeva, Kirti Shetty, Saurabh Dahiya, Aaron P Rapoport, Tim Luetkens, Djordje Atanackovic
Publikováno v:
Clinical & Translational Immunology, Vol 11, Iss 5, Pp n/a-n/a (2022)
Abstract Objectives Solid organ transplant recipients (SOTR) receiving post‐transplant immunosuppression show increased COVID‐19‐related mortality. It is unclear whether an additional dose of COVID‐19 vaccines can overcome the reduced immune
Externí odkaz:
https://doaj.org/article/93a523e0f0174ab7847532c36cefb624
Autor:
Djordje Atanackovic, Stephanie V. Avila, Forat Lutfi, Diego de Miguel-Perez, Xiaoxuan Fan, Gabriela Sanchez-Petitto, Erica Vander Mause, Jonathan Siglin, John Baddley, Heather D. Mannuel, Hanan Alkhaldi, Kim G. Hankey, Rena Lapidus, Michael Kleinberg, Joseph Rabin, Carl Shanholtz, Christian Rolfo, Aaron P. Rapoport, Saurabh Dahiya, Tim Luetkens
Publikováno v:
Communications Biology, Vol 4, Iss 1, Pp 1-12 (2021)
Atanackovic and coauthors screen COVID-19 patients for antibodies against 9 different SARS-CoV-2 proteins observing responses against the spike (S) proteins, the receptor-binding domain (RBD), and the nucleocapsid (N) protein which were of the IgG1 a
Externí odkaz:
https://doaj.org/article/fb56e5486aff47208a34a57aea2883cd
Autor:
Djordje Atanackovic, Tim Luetkens, Destiny Omili, Thierry Iraguha, Forat Lutfi, Nancy M. Hardy, Xiaoxuan Fan, Stephanie V. Avila, Kapil K. Saharia, Jennifer S. Husson, Silke V. Niederhaus, Philip Margiotta, Seung T. Lee, Jennie Y. Law, Heather D. Mannuel, Erica Vander Mause, Sherri Bauman, Patricia Lesho, Kim Hankey, John Baddley, Mehmet Kocoglu, Jean A. Yared, Aaron P. Rapoport, Saurabh Dahiya
Publikováno v:
Blood. 140:152-156
Patients receiving CD19 CAR T-cell therapy for relapsed/refractory lymphoma experience prolonged and profound B-cell aplasia and hypogammaglobulinemia, placing them at a higher risk for severe COVID-19. Independently, Oh et al and Atanackovic et al d
Autor:
Djordje Atanackovic, Tim Luetkens, Stephanie V. Avila, Nancy M. Hardy, Forat Lutfi, Gabriela Sanchez-Petitto, Erica Vander Mause, Nicole Glynn, Heather D. Mannuel, Hanan Alkhaldi, Kim Hankey, John Baddley, Saurabh Dahiya, Aaron P. Rapoport
Publikováno v:
Vaccines, Vol 9, Iss 7, p 737 (2021)
Patients after autologous (autoSCT) and allogeneic stem cell transplantation (alloSCT) are at an increased risk of COVID-19-related morbidity and mortality, compounded by an immune system weakened by the underlying malignancy and prior treatments. Al
Externí odkaz:
https://doaj.org/article/07d1d76badd5401c996d5b432ab5adcc
Autor:
Fiorella Iglesias, Siani Weston, Stephanie V. Avila, Holly Zhou, Sara Yousef, Mark Fluchel, Erin Morales, Michael L. Olsen, Sabarinath V. Radhakrishnan, Tim Luetkens
Downregulation of HLA is one of the most common tumor escape mechanisms by enabling tumors to persist in the presence of tumor-reactive T cells. HLA loss is particularly common in children with high-risk neuroblastoma, who have a 50% long-term surviv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::99ed732e2ce70f7a8be974779d195f19
https://doi.org/10.1101/2022.06.21.496901
https://doi.org/10.1101/2022.06.21.496901
Autor:
Kapil K. Saharia, Jennifer S. Husson, Silke V. Niederhaus, Thierry Iraguha, Stephanie V. Avila, Youngchae J. Yoo, Nancy M. Hardy, Xiaoxuan Fan, Destiny Omili, Alice Crane, Amber Carrier, Wen Y. Xie, Erica Vander Mause, Kim Hankey, Sheri Bauman, Patricia Lesho, Heather D. Mannuel, Ashish Ahuja, Minu Mathew, James Avruch, John Baddley, Olga Goloubeva, Kirti Shetty, Saurabh Dahiya, Aaron P. Rapoport, Tim Luetkens, Djordje Atanackovic
BackgroundSolid organ transplant recipients (SOTR), who typically receive post-transplant immunosuppression, show increased COVID-19-related mortality. It is unclear whether an additional dose of COVID-19 vaccines in SOTR can overcome the reduced imm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fa251084972f92af72b7f43c264d059d
https://doi.org/10.1101/2021.12.29.21268529
https://doi.org/10.1101/2021.12.29.21268529
Autor:
Djordje Atanackovic, Ryan A. Metcalf, Patricia R. Slev, Adam M. Spivak, Robert C. Blaylock, Vicente Planelles, Mohammad M. Sajadi, Yue Zheng, Heather D. Mannuel, Erin T. Larragoite, Mary Steinbach, Aaron P. Rapoport, Tim Luetkens, Emily S Spivak, Thomas B. Martins, Kim G. Hankey, Stephanie V. Avila
Publikováno v:
Blood Advances
Key Points A severely immunocompromised patient with MM and COVID19 who received a convalescent plasma product showed SARS-CoV-2 clearance. The convalescent plasma showed humoral immunity against all structural SARS-CoV-2 proteins, which was successf
Publikováno v:
Surgical Neurology International
Background Bilateral blunt cerebrovascular injury (BCVI) has been documented in 32 patients in the English-language literature and bilateral carotid-cavernous fistulae (CCFs) have been reported in only 1 patient. Here, we present a case of severe, un
Publikováno v:
Blood. 134:1691-1691
Hydroxyurea is usually the first line treatment for high-risk polycythemia vera (PV) and essential thrombocythemia (ET), but interferon is an equally effective treatment. However, unlike hydroxyurea, several studies have shown higher rate of molecula